Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Ligand Pharmaceuticals (LGNDZ) Goodwill (2016 - 2025)

Ligand Pharmaceuticals (LGNDZ) has disclosed Goodwill for 16 consecutive years, with $101.5 million as the latest value for Q4 2025.

  • Quarterly Goodwill fell 3.52% to $101.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $101.5 million through Dec 2025, down 3.52% year-over-year, with the annual reading at $101.5 million for FY2025, 3.52% down from the prior year.
  • Goodwill hit $101.5 million in Q4 2025 for Ligand Pharmaceuticals, roughly flat from $101.5 million in the prior quarter.
  • In the past five years, Goodwill ranged from a high of $190.5 million in Q2 2021 to a low of $3.7 million in Q3 2023.
  • Historically, Goodwill has averaged $112.0 million across 5 years, with a median of $105.2 million in 2024.
  • Biggest five-year swings in Goodwill: tumbled 44.52% in 2022 and later soared 2737.69% in 2024.
  • Year by year, Goodwill stood at $190.2 million in 2021, then dropped by 4.72% to $181.2 million in 2022, then crashed by 97.95% to $3.7 million in 2023, then skyrocketed by 2737.69% to $105.2 million in 2024, then decreased by 3.52% to $101.5 million in 2025.
  • Business Quant data shows Goodwill for LGNDZ at $101.5 million in Q4 2025, $101.5 million in Q3 2025, and $101.5 million in Q2 2025.